| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director, 10% Owner
1 company
Bankole A. Johnson last filed a Form 4 in May 2023, as Chief Medical Officer at ADIL. Bankole A. Johnson's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 148,246 shares of ADIL. The ADIL filings lean toward selling, a net 775,500 shares.
Bankole A. Johnson has 11 Form 4 filings on record from July 2018 to May 2023, all as Director at Adial Pharmaceuticals (ADIL), 2018–2023.
The 23 reported transactions were 7 other transactions, 6 open-market purchases, 4 open-market sales and 3 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $241K and 3 sales worth about $949K.
The only open-market purchase was 73,100 shares of ADIL at an average $3.29 on March 29, 2019, about $241K.
The largest open-market sale was 350,000 shares of ADIL at an average $1.21 on August 20, 2020, about $424K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 200,000 | $0.00 | - | -57.4% | -26.6% | -90.1% | |
| Apr 6, 2021 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 150,000 | $2.50 | $375,000.00 | -21.5% | +13.1% | -26.3% | |
| Aug 20, 2020 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 350,000 | $1.21 | $423,500.00 | -99.7% | - | - | |
| Dec 12, 2019 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 150,000 | $1.00 | $150,000.00 | -17.7% | - | - | |
| Mar 29, 2019 | ADIL Adial Pharmaceuticals, Inc. | Chief Medical Officer | Buy | 73,100 | $3.29 | $240,609.02 | +26.6% | - | - | |
| Jul 31, 2018 | ADIL Adial Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,400 | $0.00 | - | New | - | - |